MZF1 and breast carcinoma: Nuclear factor erythroid 2-like 2 (NRF2) and myeloid zinc finger-1 (MZF-1) could impact cancer cell growth by transcriptionally regulating FPN, FTH, and FTL expression in prostate and breast cancer [72].